Medical Science Liaison Austria
The role of the Medical Science Liaison (MSL) is a field-based key position within Novocure’s Austrian organization. The position is responsible for building relationships within the medical–scientific community, providing medical and scientific information on Novocure products and research to healthcare professionals (HCPs), and supporting these HCPs in caring for patients treated with Tumor Treating Fields (TTFields). Additional responsibilities include—but are not limited to—acting as a scientific interface between the company and HCP communities regarding communication about Novocure’s clinical development plans as well as other research and development activities. Developing appropriate training materials, supporting external research projects related to marketed or investigational Novocure indications, and participating in field-based activities to advance existing products and introduce new indications are also part of the role. The MSL plays an important role within the team, serves as a resource and mentor for other field-based employees, and is responsible for training new prescribers. Medical–scientific expertise is maintained through literature research, participation in professional congresses, and self-study. The position works closely with cross-functional partners, including the Austrian business team.
We look forward to receiving your application. More information about Novocure and our therapy can be found on our website at www.novocure.de.
*Our employees benefit from an attractive package of benefits, which may vary depending on position and area of deployment.

We are a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of our innovative therapy, Tumor Treating Fields. Our commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma. We have ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer and gastric cancer.
Headquartered in Switzerland, Novocure has U.S. operations in Portsmouth, New Hampshire and Chesterbrook, Pennsylvania. Additionally, Novocure has offices in Canada, Germany, Japan, Poland and Israel.